Related Experiment Video
Updated: May 9, 2026

11:59
Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Hematopathologic discrepancies between referral and review diagnoses: a gap between general pathologists and
Chen Chang1, Shih-Wen Huang, Ih-Jen Su
1Department of Pathology.
Leukemia & Lymphoma
|August 10, 2013
Summary
The World Health Organization (WHO) lymphoma classification shows poor reproducibility among general pathologists. This diagnostic challenge impacts patient management, particularly in regions lacking advanced ancillary techniques.
Area of Science:
- Hematopathology
- Oncology
- Diagnostic Pathology
Background:
- The World Health Organization (WHO) lymphoma classification is a standard in hematopathology.
- Its practical application and reproducibility among general pathologists remain under-evaluated.
Purpose of the Study:
- To assess the reproducibility of the WHO lymphoma classification in a real-world setting.
- To identify common sources of diagnostic discrepancies in lymphoma classification.
Main Methods:
- Retrospective review of 406 cases via a hematopathology consultation program in Taiwan.
- Diagnostic discrepancies were categorized based on potential impact on disease management using National Comprehensive Cancer Network guidelines.
Main Results:
- Major diagnostic discrepancies occurred in 55% of cases, with common issues including ambiguous referrals, tumor type revisions, and malignant-to-benign misclassifications.
- Concordance rates for B-cell and T/natural killer (NK)-cell lymphomas were 41% and 33%, respectively.
- Poor reproducibility was observed, especially in settings without widespread ancillary technique use.
Conclusions:
- The current WHO lymphoma classification system demonstrates limited reproducibility among general pathologists.
- Diagnostic discrepancies significantly impact patient management, highlighting a need for improved training and standardization.
- The findings underscore challenges in applying complex classifications without extensive ancillary support.
Related Concept Videos
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
